Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6705-6714
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6705
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6705
Figure 4 Serum levels of other markers and liver fibrosis in patients with chronic hepatitis B.
A: Aspartate aminotransferase to platelet index (APRI); B: Fibrosis index based on the four factors (FIB-4); C: Serum levels of Mac-2 binding protein glycosylation isomer (M2BPGi); D: The number of platelets (Plt); E: Serum hyaluronic acid level; F: Type4 collagen 7S; and G: P-III-P levels in patients with each liver fibrotic stage (F-Stage). Data are means ± SD, aP < 0.05, bP < 0.01.
- Citation: Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714
- URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i36.6705